100858-26-2 Usage
General Description
The chemical compound "(1R,3aR,7aR)-1-((2R,5S,E)-6-(MethoxyMethoxy)-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one" is a complex organic compound that contains various types of chemical groups. Key among these include methoxy which is a functional group characterized by a methyl group linked to oxygen, and methoxy methoxy which has two methoxy groups linked together. Other functional groups present include dimethylheptane characterized by two methyl groups on a seven-carbon chain, and hexahydro, indicative of a cyclic compound with six carbon atoms in its ring structure. Lastly, there is the presence of 1H-inden-4(2H)-one, which is a polycyclic aromatic hydrocarbon derived from indene. Overall, this molecule appears to have potential applications in organic synthesis, although exact uses or properties cannot be established without further information.
Check Digit Verification of cas no
The CAS Registry Mumber 100858-26-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,8,5 and 8 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 100858-26:
(8*1)+(7*0)+(6*0)+(5*8)+(4*5)+(3*8)+(2*2)+(1*6)=102
102 % 10 = 2
So 100858-26-2 is a valid CAS Registry Number.
100858-26-2Relevant articles and documents
PROCESS FOR PRODUCTION OF INDENE DERIVATIVE, AND INTERMEDIATE FOR PRODUCTION OF THE DERIVATIVE
-
Page/Page column 15; 16, (2009/01/24)
Indene derivatives that are utilizable as intermediates in the synthesis of the vitamin D2 derivative paricalcitol, which is useful as pharmaceutical are efficiently prepared by subjecting a vitamin D2 derivative such as 25-hydroxyvi
25-Hydroxydihydrotachysterol2. An innovative synthesis of a key metabolite of dihydrotachysterol2
Hanekamp,Rookhuizen,Bos,Brandsma
, p. 9283 - 9294 (2007/10/02)
A new synthesis of 25-hydroxydihydrotachysterol2 is described. The hydroxylated side-chain is constructed stereoselectively using a chiral Wittig reagent. The A-ring synthon is introduced utilising the Wittig-Horner method as developed by Lythgoe et al. The preparation of the metabolite is carried out in 18 steps.
